Topics

Abbott's Trial To Assess New Therapy Option For People At Risk Of Stroke

10:16 EST 3 Feb 2020 | FinanzNachrichten

NORTH CHICAGO (dpa-AFX) - Abbott (ABT) said that the U.S. Food and Drug Administration has approved a new trial designed to assess its Amplatzer Amulet Left Atrial Appendage Occluder for people wi...

Original Article: Abbott's Trial To Assess New Therapy Option For People At Risk Of Stroke

NEXT ARTICLE

More From BioPortfolio on "Abbott's Trial To Assess New Therapy Option For People At Risk Of Stroke"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...